XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Total revenues $ 1,878,000 $ 2,376,000 $ 8,956,000 $ 4,609,000
Operating expenses (income):        
Cost of revenues 1,344,000 2,511,000 8,250,000 4,954,000
Research and development 255,000 1,038,000 1,009,000 3,328,000
Gain on sale of Verdeca 0 0 (1,138,000) 0
Impairment of intangible asset 0 120,000 72,000 120,000
Change in fair value of contingent consideration (0) (0) (70,000) (140,000)
Impairment of property and equipment 24,000 1,108,000 370,000 1,319,000
(Gain) loss on sale of property and equipment 0 0 (386,000) 17,000
Selling, general and administrative 4,835,000 6,312,000 13,834,000 16,733,000
Total operating expenses 6,458,000 11,089,000 21,941,000 26,331,000
Loss from operations (4,580,000) (8,713,000) (12,985,000) (21,722,000)
Interest income (expense) 95,000 (15,000) 123,000 (23,000)
Other income (expense), net 43,000 (7,000) 13,000 10,214,000
Change in fair value of common stock warrant and option liabilities 1,880,000 4,777,000 1,880,000 4,601,000
Gain on extinguishment of PPP loan 0 1,123,000 0 1,123,000
Issuance and offering costs (314,000) 0 (314,000) (769,000)
Net loss before income taxes (2,876,000) (2,835,000) (11,283,000) (6,576,000)
Income tax provision (1,000) (1,000) (1,000) (1,000)
Net loss (2,877,000) (2,836,000) (11,284,000) (6,577,000)
Net loss attributable to non-controlling interest (10,000) (661,000) (152,000) (1,199,000)
Net loss attributable to common stockholders $ (2,867,000) $ (2,175,000) $ (11,132,000) $ (5,378,000)
Net loss per share attributable to common stockholders:        
Basic net loss per share attributable to common stockholders: $ (0.12) $ (0.10) $ (0.48) $ (0.26)
Diluted net loss per share attributable to common stockholders: $ (0.12) $ (0.10) $ (0.48) $ (0.26)
Denominator:        
Weighted average number of common shares outstanding 24,552,543 22,177,423 22,984,816 20,976,105
Weighted average number of common shares outstanding - diluted 24,552,543 22,177,423 22,984,816 20,976,105
Other Comprehensive Income (Loss), Net of Tax [Abstract]        
Foreign currency translation adjustment $ (0) $ (12,000) $ (0) $ (24,000)
Other Comprehensive loss 0 (12,000) 0 (24,000)
Comprehensive loss attributable to common stockholders (2,867,000) (2,187,000) (11,132,000) (5,402,000)
Product        
Revenues:        
Total revenues 1,851,000 2,324,000 7,967,000 4,506,000
Royalty        
Revenues:        
Total revenues 17,000 35,000 117,000 86,000
License        
Revenues:        
Total revenues $ 10,000 $ 17,000 $ 872,000 $ 17,000